Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

about

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

Item

http://www.wikidata.org/entity/Q40562961

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

@en

type

Item

label

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

@en

prefLabel

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

@en

P1476

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

@en

P2093

Carey K Anders

http://www.w3.org/2001/XMLSchema#string

Hazel B Nichols

http://www.w3.org/2001/XMLSchema#string

Jeannette T Bensen

http://www.w3.org/2001/XMLSchema#string

Kemi M Doll

http://www.w3.org/2001/XMLSchema#string

Laura Hendrix

http://www.w3.org/2001/XMLSchema#string

Suzanne N Landi

http://www.w3.org/2001/XMLSchema#string

P2860

Oestrogen therapy for urinary incontinence in post-menopausal women

Prevalence of symptomatic pelvic floor disorders in US women

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.

Urinary incontinence and health-related quality of life among older Americans with and without cancer: a cross-sectional study.

Urinary, fecal, and dual incontinence in older U.S. Adults

Urogenital effects of selective estrogen receptor modulators: a systematic review.

Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer.

Effects of estrogen with and without progestin on urinary incontinence.

P2888

s10552-016-0810-x

P304

1325-1332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10552-016-0810-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer M Wu

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050123590

http://www.w3.org/2001/XMLSchema#string

P698

27680018

http://www.w3.org/2001/XMLSchema#string

P932

5835969

http://www.w3.org/2001/XMLSchema#string